Lightbridge Successfully Co-Extrudes a Demonstration Coupon Sample with Uranium-Zirconium Alloy and Cladding
Lightbridge and INL teams at Idaho National LaboratoryRESTON, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation ...
Avita’s Road to Profitability Is in SIght as It Continues to Take the Right Steps
We view Avita’s RECELL system as a sound alternative treatment for large second- and third-degree burns treated in burn centers. It compares favorably on price and ease of use with new products and ...
Reuters Win In AI Training Lawsuit Gives Guidance On New Era of 'Fair Use,' Attorneys Say
"The ruling is, in many respects, fairly narrow, but it does provide guidance as to how to analyze some of these issues in ...
Lightbridge Corporation: Lightbridge Successfully Co-Extrudes a Demonstration Coupon Sample with Uranium-Zirconium Alloy and Cladding
Lightbridge and INL teams at Idaho National Laboratory RESTON, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation ...
Bio-Rad's Expanding Profit Margins and Stake in Sartorius Drive Long-Term Value
As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...
Design-Reuse19d
A Security Tagging Scheme for ASIC Designs and Intellectual Property Cores
‘Overbuild’ a licensed product – i.e. they produce more units than the license allows or they have paid royalty ... taking the time to check the exact details of the licence agreement associated with ...
Contract Pharma18h
atai Acquires Psilera’s DMT Patent Portfolio
Dr. Srinivas Rao, Co-Founder and CEO of atai, added, “This agreement strengthens our DMT patent portfolio and enables us to ...
Managingip.com7d
China: Vertical monopolistic agreements in digital music’s ‘exclusive copyright + sub-licensing' model
Charles Feng, Lian Xue, and Yetong Liu of Tahota Law Firm examine whether the model constitutes a monopolistic agreement and ...
Axsome announces settlement agreement resolving AUVELITY patent litigation
Axsome Therapeutics (AXSM) announced that it has entered into a settlement agreement with Teva Pharmaceuticals (TEVA) resolving all patent ...